ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
발기부전 치료제 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 8.9%의 연평균 복합 성장률(CAGR)로 37억 8,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안 성장의 원동력은 심리적 요인 증가, 비만 및 대사 이상 비율 증가, 비침습적 발기부전 치료에 대한 수요 증가, 성 건강 관련 환자 상담 건수 증가, 남성 건강 증진 및 생활습관 관련 위험 요인에 대한 정부 이니셔티브 증가 등이 될 것으로 예측됩니다. 등이 예상됩니다. 주요 동향으로는 발기부전 치료제의 전자 약국 확대, 음경 임플란트 기술의 발전, 발기부전 진단의 기술 혁신, 발기부전의 근본 원인을 겨냥한 새로운 치료법 개발, 보다 효과적인 포스포디에스터라아제 5형 억제제 도입 등을 들 수 있습니다.
생활습관병의 유병률 증가는 발기부전 시장의 성장을 가속할 것으로 예측됩니다. 생활습관병은 주로 불규칙한 식습관, 운동 부족, 흡연, 과도한 음주와 같은 건강에 해로운 습관으로 인해 발생합니다. 이러한 질환을 증가시키는 요인으로는 좌식생활 증가, 식습관 장애, 스트레스, 불건강한 습관 등이 있습니다. 발기부전(ED)은 심혈관계 질환과 당뇨병을 포함한 생활습관병의 조기 지표가 되는 경우가 많아 적시에 의료적 개입과 건강한 생활습관 개선이 중요하다는 점을 강조하고 있습니다. 예를 들어, 2022년 5월 영국의 비영리단체인 세계비만연맹은 2030년까지 전 세계 10억 명(여성 5명 중 1명, 남성 7명 중 1명)이 비만과 함께 생활할 것으로 예측된다고 보고했습니다. 이 수치는 2035년까지 전 세계 인구의 51%에 해당하는 40억 명이 과체중 또는 비만이 될 것으로 예측됩니다. 따라서 생활습관병 유병률 증가는 발기부전 치료제 시장의 성장을 가속할 것으로 예측됩니다.
발기부전 치료제 시장의 주요 업체들은 발기부전 환자들에게 더 쉽고 편리한 치료 옵션을 제공하기 위해 일반의약품(OTC) 젤과 같은 혁신적인 제품 개발에 주력하고 있습니다. OTC 젤은 처방전 없이 구입할 수 있는 외용제로, 특정 증상을 치료하기 위해 피부에 직접 바르는 외용제로, 시장 도달 범위를 넓히고 미충족된 환자 니즈를 충족시키는 것을 목표로 하고 있습니다. 예를 들어, 2024년 9월 영국 소비자 헬스케어 기업 Haleon plc는 발기부전 치료제로는 최초로 FDA 승인을 받은 발기부전 치료제인 Eroxon을 출시했습니다. 이 획기적인 제품은 비침습적이고 즉각적인 솔루션을 제공하여 환자의 편의성을 향상시킬 수 있도록 설계되었습니다. 이 제품은 외용제이기 때문에 복용할 필요가 없으며, 잠재적인 전신 부작용을 줄이고, 대체 치료 옵션을 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 발기부전 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 발기부전 시장 : 성장률 분석
세계의 발기부전 시장 실적 : 규모와 성장, 2019-2024
세계의 발기부전 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 발기부전 전체 시장(TAM)
제6장 시장 세분화
세계의 발기부전 시장 : 제품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
약물
디바이스
세계의 발기부전 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 채널
세계의 발기부전 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
병원 및 진료소
외래수술센터(ASC)
약국
기타 최종사용자
세계의 발기부전 시장 : 약물 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
포스포디에스테라아제 5형(PDE5) 억제제
호르몬 요법
주사약
외용약
세계의 발기부전 시장 : 디바이스 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
진공 발기 장치(VED)
음경 임플란트
충격파 치료 장비
제7장 지역별/국가별 분석
세계의 발기부전 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 발기부전 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
발기부전 시장 : 경쟁 구도
발기부전 시장 : 기업 개요
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Dong-A Socio Holdings Co. Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi S.A. : 개요, 제품 및 서비스, 전략 및 재무 분석
GlaxoSmithKline plc : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Eli Lilly and Company
Viatris Inc.
Teva Pharmaceutical Industries Limited
Boston Scientific Corporation
Sandoz International GmbH
Sun Pharmaceutical Industries Limited
Coloplast Corporation
Dr. Reddy's Laboratories Limited
Cipla Limited
Ferring Pharmaceuticals A/S
Endo International plc
Zydus Lifesciences Limited
Lupin Limited
Hims & Hers Health Inc.
Cadila Pharmaceuticals Limited
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
발기부전 시장(2029년) : 새로운 기회를 제공하는 국가
발기부전 시장(2029년) : 새로운 기회를 제공하는 부문
발기부전 시장(2029년) : 성장 전략
시장 동향에 근거한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Erectile dysfunction (ED) is the inability to achieve or sustain an erection adequate for satisfactory sexual performance. It is a prevalent condition influenced by physical, psychological, and lifestyle factors, impacting men's overall well-being and quality of life.
The primary product categories for erectile dysfunction include drugs and devices. Drugs are chemical formulations designed to improve blood flow to the penis, enabling men to attain and maintain an erection. These products are distributed through hospital pharmacies, retail pharmacies, and online channels, serving end users such as hospitals and clinics, ambulatory surgery centers, pharmacies, and other healthcare providers.
The erectile dysfunction market research report is one of a series of new reports from The Business Research Company that provides erectile dysfunction market statistics, including erectile dysfunction industry global market size, regional shares, competitors with an erectile dysfunction market share, detailed erectile dysfunction market segments, market trends and opportunities, and any further data you may need to thrive in the erectile dysfunction industry. This erectile dysfunction market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The erectile dysfunction market size has grown strongly in recent years. It will grow from $2.46 billion in 2024 to $2.69 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period was driven by the increasing incidence of cardiovascular diseases, the rising prevalence of diabetes, greater awareness of erectile dysfunction as a medical condition, an aging population contributing to higher ED cases, and a growing preference for personalized treatment options.
The erectile dysfunction market size is expected to see strong growth in the next few years. It will grow to $3.78 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period is expected to be driven by an increase in psychological factors, higher rates of obesity and metabolic disorders, rising demand for non-invasive erectile dysfunction treatments, a growing number of patient consultations for sexual health, and increasing government initiatives promoting men's health and addressing lifestyle-related risk factors. Key trends include the expansion of e-pharmacies for erectile dysfunction drugs, advancements in penile implant technologies, technological innovations in erectile dysfunction diagnostics, the development of novel treatment methods targeting the root causes of ED, and the introduction of more effective phosphodiesterase type 5 inhibitors.
The increasing prevalence of lifestyle-related diseases is expected to drive growth in the erectile dysfunction market. Lifestyle-related diseases are primarily caused by unhealthy habits such as poor diet, lack of physical activity, smoking, and excessive alcohol consumption. Factors contributing to the rise in these conditions include increased sedentary behavior, poor dietary choices, stress, and unhealthy habits. Erectile dysfunction (ED) is often an early indicator of lifestyle-related diseases, including cardiovascular conditions and diabetes, emphasizing the importance of timely medical intervention and healthier lifestyle changes. For example, in May 2022, the World Obesity Federation, a UK-based non-profit organization, reported that by 2030, one billion people worldwide equivalent to one in five women and one in seven men are projected to be living with obesity. This figure is expected to rise to four billion people, or 51% of the global population, who will be either overweight or obese by 2035. The increasing prevalence of lifestyle-related diseases is, therefore, expected to drive the growth of the erectile dysfunction market.
Leading companies in the erectile dysfunction market are focusing on developing innovative products, such as over-the-counter (OTC) gels, to provide more accessible and convenient treatment options for individuals with ED. This approach aims to expand market reach and address unmet patient needs. An OTC gel is a topical medication available without a prescription, applied directly to the skin to treat specific conditions. For instance, in September 2024, Haleon plc, a UK-based consumer healthcare company, introduced Eroxon, the first FDA-cleared over-the-counter gel for erectile dysfunction. This groundbreaking product offers a non-invasive, fast-acting solution designed to improve accessibility and convenience for patients. Its topical application eliminates the need for oral medications, reducing potential systemic side effects and providing an alternative treatment option.
In September 2022, Advanced MedTech Holdings, a Singapore-based medical device company, acquired Shenzhen Wikkon Medical Apparatus Co. Ltd. for an undisclosed amount. This acquisition strengthens Advanced MedTech Holdings' presence in the urology sector in China by leveraging Wikkon's expertise in developing and manufacturing urology and shock wave therapy devices. Shenzhen Wikkon Medical Apparatus Co. Ltd., a China-based company, specializes in extracorporeal shock wave therapy (ESWT) for treating conditions such as erectile dysfunction and urinary stones.
Major players in the erectile dysfunction market are Pfizer Inc., Bayer AG, Dong-A Socio Holdings Co. Ltd., Sanofi S.A., GlaxoSmithKline plc, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Limited, Boston Scientific Corporation, Sandoz International GmbH, Sun Pharmaceutical Industries Limited, Coloplast Corporation, Dr. Reddy's Laboratories Limited, Cipla Limited, Ferring Pharmaceuticals A/S, Endo International plc, Zydus Lifesciences Limited, Lupin Limited, Hims & Hers Health Inc., Cadila Pharmaceuticals Limited, VIVUS Inc., Rigicon Inc., Petros Pharmaceuticals Inc., Futura Medical plc, Apricus Biosciences Inc., Pos-T-Vac Medical Inc., Initiator Pharma A/S.
North America was the largest region in the erectile dysfunction market in 2024. The regions covered in erectile dysfunction report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the erectile dysfunction market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The erectile dysfunction market consists of sales of medications, devices, and therapies aimed at treating erectile dysfunction. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Erectile Dysfunction Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on erectile dysfunction market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for erectile dysfunction ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The erectile dysfunction market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Drugs; Devices
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Channels
3) By End User: Hospitals And Clinics; Ambulatory Surgery Centers; Pharmacies; Other End Users
Subsegments:
1) By Drugs: Phosphodiesterase Type 5 (PDE5) Inhibitors; Hormone Therapy; Injectable Medications; Topical Medications
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Erectile Dysfunction Market Characteristics
3. Erectile Dysfunction Market Trends And Strategies
4. Erectile Dysfunction Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Erectile Dysfunction Growth Analysis And Strategic Analysis Framework
5.1. Global Erectile Dysfunction PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Erectile Dysfunction Market Growth Rate Analysis
5.4. Global Erectile Dysfunction Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Erectile Dysfunction Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Erectile Dysfunction Total Addressable Market (TAM)
6. Erectile Dysfunction Market Segmentation
6.1. Global Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drugs
Devices
6.2. Global Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Channels
6.3. Global Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Ambulatory Surgery Centers
Pharmacies
Other End Users
6.4. Global Erectile Dysfunction Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Phosphodiesterase Type 5 (PDE5) Inhibitors
Hormone Therapy
Injectable Medications
Topical Medications
6.5. Global Erectile Dysfunction Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vacuum Erection Devices (VEDs)
Penile Implants
Shockwave Therapy Devices
7. Erectile Dysfunction Market Regional And Country Analysis
7.1. Global Erectile Dysfunction Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Erectile Dysfunction Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
